IAPs: guardians of RIPK1

Area of Science:

• Molecular Biology
• Immunology
• Oncology

Background:

• Deregulation of innate immune signaling and cell death underlies many human diseases.
• Inhibitors of Apoptosis (IAPs) are overexpressed in cancer, promoting tumor survival and chemoresistance.
• IAPs regulate caspases and influence innate immune signaling via NF-κB activation.

Purpose of the Study:

• To review current understanding of IAP-mediated NF-κB signaling.
• To elaborate on the role of IAPs in regulating the Ripoptosome, a novel cell death platform.
• To propose IAPs as evolutionarily conserved guardians of cell death platforms.

Main Methods:

• Literature review of IAP function in cell death and innate immunity.
• Analysis of molecular mechanisms of IAP-mediated NF-κB signaling.
• Exploration of IAP involvement in the Ripoptosome complex.

Main Results:

• IAPs play a dual role in regulating both cell death and innate immune responses.
• IAPs are crucial in modulating NF-κB activation through ubiquitin-dependent pathways.
• IAPs are involved in the formation and regulation of the Ripoptosome, a key cell death platform.

Conclusions:

• IAPs are critical regulators of cell death and innate immunity with implications for cancer pathogenesis.
• Targeting IAP-mediated pathways, including NF-κB and the Ripoptosome, presents novel therapeutic strategies for cancer.
• IAPs act as conserved guardians of essential cell death machinery, such as the apoptosome and Ripoptosome.